Skip to main content
. 2015 Aug 8;2(9):1251–1256. doi: 10.1016/j.ebiom.2015.08.011

Table 2.

Summary of outcomes, number of participants or median values given for summary.

Outcome Control “face-to-face” Missing, n (%) Intervention “telephone” Missing, n (%) Adjusted treatment effect
(95% CI)
P
IMPACT QOL score at 12 months 106
(95, 116)
6
(14)
113
(105, 125)
13
(30)
5.7
(− 2.9, 14.3)
0.19
Disease relapses over 24 months 4
(10)
1
(2)
0.20
BMI z-score at 12 months 0.020
(− 0.85, 1.02)
11
(26)
0.329
(− 0.63, 0.57)
19
(44)
0.34
(− 0.02, 0.69)
0.06
Weight z-score at 12 months 0.39
(− 0.86, 0.96)
11
(26)
0.548
(− 0.35, 1.04)
19
(44)
0.08
(− 0.22, 0.37)
0.59
Height z-score at 12 months − 0.13
(− 0.85, 1.07)
11
(26)
0.21
(− 0.53, 1.50)
19
(44)
− 0.04
(− 0.32, 0.24)
0.79
CSQ-child (modified) by 24 months 46
(44, 51)
2
(5)
48
(45, 51)
8
(18)
0.59
(− 2.05, 3.24)
0.65
CSQ-parent (modified) by 24 months 48
(44, 52)
2
(5)
48
(45, 51)
8
(18)
0.44
(− 2.01, 2.89)
0.72
Proportion of out-patient consultations attended over 24 months, % 71
(50, 80)
0
(0)
67
(50, 75)
1
(2)
1.06
(0.784, 1.43)
0.71
Duration of consultations over 24 months, mins 14.3
(11.6, 17.0)
1
(2)
9.8
(8, 12.3)
3
(7)
4.3
(2.8, 5.7)
< 0.001